TP53 and neoplasm: Widespread inhibition of p63 DNA binding by p53 DNA-binding mutants seems to be ruled out by our experiments: >3400 p63 locations are retrieved in a cellular context with very high levels of tumor-type mutp53, up to 20-fold excess with respect to p63 [15].